Recently published epidemiological and genetic studies strongly suggest a causal
relationship of elevated concentrations of lipoprotein (a)[Lp (a)] with cardiovascular disease …

Abstract Purpose of Review The purpose of this article is to review current evidence for
lipoprotein (a)(Lp (a)) as a risk factor for multiple cardiovascular (CV) disease phenotypes …

Lipoprotein (a)(Lp (a)) is a complex circulating lipoprotein, and increasing evidence has
demonstrated its role as a risk factor for atherosclerotic cardiovascular disease (ASCVD) …

Evidence that elevated lipoprotein (a)(Lp [a]) levels contribute to cardiovascular disease
(CVD) and calcific aortic valve stenosis (CAVS) is substantial. Development of isoform …

Abstract Background Lipoprotein (a)(Lp (a)) is a CVD risk factor amenable to intervention
and might help guide risk prediction. Objectives To investigate the population attributable …

Aims To investigate the population attributable fraction due to elevated lipoprotein (a)(Lp (a))
and the utility of measuring Lp (a) in cardiovascular disease (CVD) risk prediction. Methods …

Abstract Purpose of Review To review the current recommendations for lipoprotein (a)(Lp
(a)) screening, the evidence behind the thresholds for increased cardiovascular disease …

Abstract High lipoprotein (a)[Lp (a)] levels are associated with the development of
atherosclerotic cardiovascular disease (ASCVD) and with calcific aortic valve stenosis …

Although numerous studies since the 1960s have identified increased plasma
concentrations of lipoprotein (a)[Lp (a)] as a risk factor for coronary heart disease (CHD), the …

Purpose To review current knowledge of elevated lipoprotein (a)[Lp (a)] levels in relation to
atherosclerotic cardiovascular disease (ASCVD) and discuss their potential use as …